Strengths: no financial debt; 54.2 million dollars of cash at March 31, 2026; high product gross margin; tangible progress on access.
Constraints: Q1 2026 operating cash outflow of ~11.8 million dollars, with full‑year OpEx guide of 54 to 58 million dollars; runway therefore depends on rapid revenue scaling, potential APAC milestones, and working‑capital discipline.
Warrant and equity overhang is meaningful (about 4.44 million warrants outstanding including 0.95 million pre‑funded), which can dilute future equity value. Management guides to operating profitability in 2027, but execution risk is material.







